Freedom Investment Management, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2020$135,000
-38.4%
54,735
-21.1%
0.02%
-37.5%
Q3 2020$219,000
-5.6%
69,409
-12.8%
0.02%
-4.0%
Q2 2020$232,000
-23.7%
79,590
-8.0%
0.02%
-7.4%
Q1 2020$304,000
+9.0%
86,509
+0.8%
0.03%
+8.0%
Q4 2019$279,000
+37.4%
85,858
-8.5%
0.02%
+38.9%
Q3 2019$203,000
-40.8%
93,875
-14.0%
0.02%
-37.9%
Q2 2019$343,000
-24.1%
109,150
-10.2%
0.03%
-19.4%
Q1 2019$452,000
+30.6%
121,484
+1.9%
0.04%
+33.3%
Q4 2018$346,000
+13.1%
119,256
-6.5%
0.03%
+42.1%
Q3 2018$306,000
+5.2%
127,504
+2.7%
0.02%
+5.6%
Q2 2018$291,000
-55.6%
124,202
-44.3%
0.02%
-45.5%
Q1 2018$655,000
+7.9%
222,954
+0.6%
0.03%
+6.5%
Q4 2017$607,000
-17.8%
221,686
+1.9%
0.03%
-24.4%
Q3 2017$738,000
+28.3%
217,577
-6.6%
0.04%
+24.2%
Q2 2017$575,000
+9.3%
232,933
+0.5%
0.03%
+6.5%
Q1 2017$526,000
-5.4%
231,808
-11.6%
0.03%
-11.4%
Q4 2016$556,000
-50.6%
262,309
-21.9%
0.04%
-51.4%
Q3 2016$1,125,000
+3.0%
335,764
-3.5%
0.07%
-2.7%
Q2 2016$1,092,000
+0.6%
347,925
+6.8%
0.07%
-6.3%
Q1 2016$1,085,000
+9.6%
325,792
+16.5%
0.08%
+5.3%
Q4 2015$990,000
+51.8%
279,685
+52971.2%
0.08%
+13.6%
Q3 2015$652,000
-43.2%
527
-99.7%
0.07%
-44.1%
Q2 2015$1,148,000
+32.9%
178,526
+45.5%
0.12%
+24.2%
Q1 2015$864,000
+87.0%
122,701
+104.7%
0.10%
+58.3%
Q4 2014$462,000
+148.4%
59,949
+140.5%
0.06%
+81.8%
Q3 2014$186,00024,9300.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders